Search

Displaying results 8371 - 8380 of 10000 in total
  1. Drug

    Pilavapadin

    go.drugbank.com/drugs/DB21552
    Investigational

    Pilavapadin is a small molecule drug. Pilavapadin is under investigation in clinical trial NCT06203002 (A Dose-ranging Study in Patients With Diabetic Peripheral Neuropathic Pain (DPNP)).

  2. Drug

    Acediasulfone

    go.drugbank.com/drugs/DB08926
    Experimental

    Acediasulfone (INN) is an antimicrobial and antimalarial long-acting prodrug of dapsone.

  3. Drug

    Cadaverine

    go.drugbank.com/drugs/DB03854
    Experimental

    Cadaverine is a foul-smelling diamine formed by bacterial decarboxylation of lysine.

  4. Drug

    UK-390957

    go.drugbank.com/drugs/DB11719
    Investigational

    UK-390,957 has been used in trials studying the treatment of Ejaculation.

  5. Drug

    JNJ-27390467

    go.drugbank.com/drugs/DB06962
    Experimental

    JNJ-27390467 is a potent, nonpeptide inhibitor of human mast cell tryptase.

  6. Drug

    Macelignan

    go.drugbank.com/drugs/DB14129
    Investigational

    Macelignan is an NSAID with antioxidant, free radical scavenging, and neuroprotective activities.

    Synonyms: (8R,8'S)-7-(3,4-methylenedioxyphenyl)-7'-(4-hydroxy-3-methoxyphenyl)-8,8'-dimethylbutane
  7. Drug

    Liafensine

    go.drugbank.com/drugs/DB14878
    Investigational

    Liafensine is under investigation in clinical trial NCT00892840 (Multiple-Ascending Dose Study).

  8. Drug

    Biomodulin T

    go.drugbank.com/drugs/DB16529
    Experimental

    Biomodulin T is a polypeptide fraction from bovine thymus with immunomodulatory effects.

  9. Drug

    N-oleoyldopamine

    go.drugbank.com/drugs/DB17036
    Experimental

    N-oleoyldopamine (OLDA) is an amide of dopamine and oleic acid.[A253042]

  10. Drug

    PI-103

    go.drugbank.com/drugs/DB17046
    Experimental

    PI-103 is an inhibitor of p110α of class I PI3K.[A253092]